These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29602736)

  • 21. The Investigation of Relationship between Coronary Artery Ectasia, Benign Prostatic Enlargement, and Lower Urinary Tract Symptoms.
    İnci M; Baydilli N; Akçay AB; Demirtaş A; Rifaioğlu MM; Gözükara KH; Kaya MG
    Urology; 2015 Jun; 85(6):1436-40. PubMed ID: 25865115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review.
    Presicce F; De Nunzio C; Tubaro A
    Curr Urol Rep; 2018 Jul; 19(9):70. PubMed ID: 29987480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement.
    De Nunzio C; Brassetti A; Proietti F; Deroma M; Esperto F; Tubaro A
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):287-292. PubMed ID: 29203892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Syndrome Does Not Increase the Risk of Ejaculatory Dysfunction in Patients With Lower Urinary Tract Symptoms and Benign Prostatic Enlargement: An Italian Single-center Cohort Study.
    De Nunzio C; Lombardo R; Gacci M; Nacchia A; Presicce F; Alkhatatbeh H; Serni S; Tubaro A
    Urology; 2017 Jul; 105():85-90. PubMed ID: 28412335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Different Metabolic Syndrome: Definitions on the Relationship Between Metabolic Syndrome and LUTS in Men With Benign Prostatic Enlargement.
    Zorba OÜ; Uzun H; Akça G; Yazar S
    Am J Mens Health; 2017 Jan; 11(1):158-163. PubMed ID: 26993995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
    Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
    Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Complex Relationship Between Lower Urinary Tract Symptoms and Sexual Health.
    Zhao H; Kim HH
    Curr Urol Rep; 2019 Aug; 20(10):58. PubMed ID: 31468204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms.
    Russo GI; Castelli T; Privitera S; Fragalà E; Favilla V; Reale G; Urzì D; La Vignera S; Condorelli RA; Calogero AE; Cimino S; Morgia G
    BJU Int; 2015 Nov; 116(5):791-6. PubMed ID: 25601421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis.
    Gacci M; Corona G; Sebastianelli A; Serni S; De Nunzio C; Maggi M; Vignozzi L; Novara G; McVary KT; Kaplan SA; Gravas S; Chapple C
    Eur Urol; 2016 Nov; 70(5):788-796. PubMed ID: 27451136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging Are Correlated With Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-assisted Radical Prostatectomy for Prostate Cancer.
    Grivas N; van der Roest R; Tillier C; Schouten D; van Muilekom E; Schoots I; van der Poel H; Heijmink S
    Urology; 2017 Sep; 107():196-201. PubMed ID: 28601562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of silodosin in patients with LUTS/BPE non responding to medical treatment with tamsulosin: a prospective, open-label, pilot study.
    Masciovecchio S; Di Pasquale AB; Ranieri G; Romano G; Di Clemente L
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4941-4945. PubMed ID: 29164564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraprostatic injections for lower urinary tract symptoms/benign prostatic enlargement treatment.
    Lombardo R; Andersson KE; Tubaro A; De Nunzio C
    Minerva Urol Nefrol; 2018 Dec; 70(6):570-578. PubMed ID: 30298711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrinology of the Aging Prostate: Current Concepts.
    Cannarella R; Condorelli RA; Barbagallo F; La Vignera S; Calogero AE
    Front Endocrinol (Lausanne); 2021; 12():554078. PubMed ID: 33692752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males.
    Heo JE; Kim DG; Yoo JW; Lee KS
    Aging Male; 2023 Dec; 26(1):6-12. PubMed ID: 36633207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.